Integralis

Company Overview

Snapshot

Founded in January 2006 by Dan Sadeh Hochstadter, Integralis operates with 1–10 employees. The company is currently in the R&D product stage, focusing on developing its AI diagnostic system.

Business overview

Integralis is a digital health company specializing in an AI diagnostic system designed to predict sepsis in premature newborns days before clinical symptoms manifest. Its core product, Inbar Ralis, aims to detect late-onset sepsis in premature neonates 36 to 48 hours in advance, thereby improving patient outcomes, reducing hospitalization costs, and minimizing antibiotic use. The company operates within the Health Tech & Life Sciences sector, specifically targeting the digital healthcare and digital medical diagnostics markets globally.

Company Intelligence Q&A

What is Integralis' primary focus?

Integralis is focused on developing an AI diagnostic system for predicting sepsis in premature newborns.

When was Integralis founded?

Integralis was founded in January 2006.

Who founded Integralis?

Integralis was founded by Dan Sadeh Hochstadter.

What is the key benefit of Integralis' technology?

Integralis' system can predict late-onset sepsis in premature neonates 36 to 48 hours before clinical symptoms appear, aiming to save lives and reduce healthcare costs.

In which sector does Integralis primarily operate?

Integralis operates primarily in the Health Tech & Life Sciences sector, with a focus on Digital Healthcare and Digital Medical Diagnostics.